BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2
73 results:

  • 1. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin lymphoma Cell Lines.
    Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies.
    R P; Shanmugam G; Rakshit S; Sarkar K
    Pathol Res Pract; 2024 Jan; 253():155026. PubMed ID: 38118219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Features and Genetic Analysis of Taiwanese Primary Immunodeficiency Patients with Prolonged Diarrhea and Monogenetic Inflammatory Bowel Disease.
    Lee WI; Chen CC; Chen SH; Lai WT; Jaing TH; Ou LS; Liang CJ; Kang CC; Huang JL
    J Clin Immunol; 2023 Aug; 43(6):1455-1467. PubMed ID: 37202577
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
    Eikeland SA; Smeland KB; Simensen VC; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
    Acta Oncol; 2023 Jan; 62(1):80-88. PubMed ID: 36715320
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sinonasal diffuse large B-cell lymphoma in a patient with Wiskott-Aldrich syndrome: A case report and literature review.
    Sun X; Luo C; Tang R; Mao S; Zhu Y; Fei C; Wang M; Tan S; Zhang S; Zhou J; Lin H; Li Z; Zhang W
    Front Immunol; 2022; 13():1062261. PubMed ID: 36713385
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity.
    Ahmed S; Miller WT
    J Biol Chem; 2022 Dec; 298(12):102664. PubMed ID: 36334623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia.
    Melén CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlén HR; Christensson B; Sander B; Wahlin BE
    Leuk Lymphoma; 2022 Jun; 63(6):1387-1397. PubMed ID: 35037561
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study.
    Reece AS; Hulse GK
    BMC Cancer; 2021 Sep; 21(1):984. PubMed ID: 34479489
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care.
    Agarwal N; Citla Sridhar D; Malay S; Patil N; Shekar A; Ahuja S; Dalal J
    Sci Rep; 2021 Feb; 11(1):4654. PubMed ID: 33633315
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
    Zhong J; Yu X; Zhang X
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms.
    Hong J; Lee JH; Byun JM; Lee JY; Koh Y; Shin DY; Lee JO; Hwang SM; Choi HS; Kim I; Yoon SS; Bang SM
    Blood Adv; 2019 Nov; 3(22):3700-3708. PubMed ID: 31765478
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome protein (wasp) is a tumor suppressor in T cell lymphoma.
    Menotti M; Ambrogio C; Cheong TC; Pighi C; Mota I; Cassel SH; Compagno M; Wang Q; Dall'Olio R; Minero VG; Poggio T; Sharma GG; Patrucco E; Mastini C; Choudhari R; Pich A; Zamo A; Piva R; Giliani S; Mologni L; Collings CK; Kadoch C; Gambacorti-Passerini C; Notarangelo LD; Anton IM; Voena C; Chiarle R
    Nat Med; 2019 Jan; 25(1):130-140. PubMed ID: 30510251
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel Peptide from Vespa ducalis Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways.
    Wu R; Li D; Tang Q; Wang W; Xie G; Dou P
    Biol Pharm Bull; 2018; 41(4):458-464. PubMed ID: 29607921
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases.
    Lee WI; Chen CC; Jaing TH; Ou LS; Hsueh C; Huang JL
    Sci Rep; 2017 Jun; 7(1):3669. PubMed ID: 28623282
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NPM-ALK phosphorylates wasp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.
    Murga-Zamalloa CA; Mendoza-Reinoso V; Sahasrabuddhe AA; Rolland D; Hwang SR; McDonnell SR; Sciallis AP; Wilcox RA; Bashur V; Elenitoba-Johnson K; Lim MS
    Oncogene; 2017 Apr; 36(15):2085-2094. PubMed ID: 27694894
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome.
    Vignesh P; Suri D; Rawat A; Lau YL; Bhatia A; Das A; Srinivasan A; Dhandapani S
    Pediatr Blood Cancer; 2017 Jan; 64(1):106-109. PubMed ID: 27566838
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.
    Kritikou JS; Dahlberg CI; Baptista MA; Wagner AK; Banerjee PP; Gwalani LA; Poli C; Panda SK; Kärre K; Kaech SM; Wermeling F; Andersson J; Orange JS; Brauner H; Westerberg LS
    Sci Rep; 2016 Aug; 6():30636. PubMed ID: 27477778
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome.
    Zhang X; Dai R; Li W; Zhao H; Zhang Y; Zhou L; Du H; Luo G; Wu J; Niu L; An Y; Zhang Z; Ding Y; Song W; Liu C; Zhao X
    Blood; 2016 Jun; 127(25):3180-91. PubMed ID: 27170596
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.
    Kampa-Schittenhelm KM; Salitzky O; Akmut F; Illing B; Kanz L; Salih HR; Schittenhelm MM
    BMC Cancer; 2016 Jan; 16():25. PubMed ID: 26775260
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.